Valo therapeutics and immunoscape collaboration identifies immunogenic peptides to develop pan coronavirus vaccine
Proteins were separated by SDS-PAGE electrophoresis and transferred onto a PVDF membrane
Tsujii S, Ishisaka M, Shimazawa M, Hashizume T, Hara H
All information provided here is for educational and reference purposes only and does not constitute medical or clinical guidance
Glutathione IV therapy delivers this compound directly into the bloodstream, allowing higher concentrations to circulate at the cellular level than oral supplementation typically allows
25, 38, 39 The combination of BSO (200 M) and L-PAM (25 M) achieved very strong synergism (CIN 0.1) in RPMI-8226 ( TP53 , KRAS and EGFR mutations) and U266 ( TP53 -mutation) cell lines, 38, 40 and strong synergism (CIN 0.10.3) was seen in MM.1S ( TP53 -wt and t(14;16)), KMS-12-PE (t(11;14) (q13;q32)) and EJM ( TP53 -mutation)